A. Böcker

发表

Status of HTS Data Mining Approaches

Gisbert Schneider, Andreas Teckentrup, Alexander Böcker, 2004 .

Development of Specific “Drug‐Like Property” Rules for Carboxylate‐Containing Oral Drug Candidates

O. Hucke, P. Bonneau, A. Böcker, 2010, ChemMedChem.

Plants Release Precursors of Histone Deacetylase Inhibitors to Suppress Growth of Competitors[OPEN]

O. Kohlbacher, Claude Becker, D. Weigel, 2015, Plant Cell.

Kaempferol, a new nutrition-derived pan-inhibitor of human histone deacetylases.

C. Busch, A. Böcker, S. Bischoff, 2013, The Journal of nutritional biochemistry.

Transient opening of the perineurial barrier for analgesic drug delivery

C. Sommer, A. Böcker, I. Blasig, 2012, Proceedings of the National Academy of Sciences.

A peptidomimetic tight junction modulator to improve regional analgesia.

A. Böcker, I. Blasig, H. Rittner, 2012, Molecular pharmaceutics.

Supplementary Information GPCR Targeted Library Design : Novel Dopamine D 3 Receptor Ligands

G. Schneider, B. C. Sasse, H. Stark, 2007 .

Absence of complement receptor type 3 and lymphocyte function antigen 1 causing deficient phagocyte and lymphocyte functions

R. Zinkernagel, V. Wahn, A. Böcker, 1988, European Journal of Pediatrics.

6- and 8-Prenylnaringenin, Novel Natural Histone Deacetylase Inhibitors Found in Hops, Exert Antitumor Activity on Melanoma Cells

C. Busch, C. Garbe, A. Böcker, 2018, Cellular Physiology and Biochemistry.

Epigenetic Impacts of Ascorbate on Human Metastatic Melanoma Cells

C. Busch, C. Garbe, A. Böcker, 2014, Front. Oncol..

Resveratrol as a Pan-HDAC Inhibitor Alters the Acetylation Status of Jistone Proteins in Human-Derived Hepatoblastoma Cells

C. Busch, A. Böcker, S. Bischoff, 2013, PloS one.

Correction: Resveratrol as a Pan-HDAC Inhibitor Alters the Acetylation Status of Jistone Proteins in Human-Derived Hepatoblastoma Cells

C. Busch, A. Böcker, S. Bischoff, 2013, PLoS ONE.

A Hierarchical Clustering Approach for Large Compound Libraries

Gisbert Schneider, Andreas Teckentrup, Alexander Böcker, 2005, J. Chem. Inf. Model..

Discovery of inhibitors of microglial neurotoxicity acting through multiple mechanisms using a stem-cell-based phenotypic assay.

Alexander Böcker, Christiane Peiker, Peter Reinhardt, 2012, Cell stem cell.

HTS Promiscuity Analyses for Accelerating Decision Making

Alexander Böcker, Paul J Edwards, Pierre R Bonneau, 2011, Journal of biomolecular screening.

Identification of 12/15-Lipoxygenase as a Regulator of Axon Degeneration through High-Content Screening

A. Böcker, Yichin Liu, J. Krämer, 2015, The Journal of Neuroscience.

Preclinical Efficacy and Toxicity Analysis of the Pan-Histone Deacetylase Inhibitor Gossypol for the Therapy of Colorectal Cancer or Hepatocellular Carcinoma

C. Busch, A. Böcker, S. Bischoff, 2022, Pharmaceuticals.

Searching for drug scaffolds with 3D pharmacophores and neural network ensembles.

Gisbert Schneider, Michael Schmuker, Steffen Renner, 2007, Angewandte Chemie.

Toward an Improved Clustering of Large Data Sets Using Maximum Common Substructures and Topological Fingerprints

Alexander Böcker, A. Böcker, 2008, J. Chem. Inf. Model..

Resveratrol as a Pan-HDAC Inhibitor Alters the Acetylation Status of Jistone Proteins in Human-Derived Hepatoblastoma Cells

C. Busch, A. Böcker, S. Bischoff, 2013, PloS one.

GPCR Targeted Library Design: Novel Dopamine D3 Receptor Ligands

G. Schneider, H. Stark, A. Böcker, 2007, ChemMedChem.

A peptidomimetic tight junction modulator to improve regional analgesia.

A. Böcker, I. Blasig, H. Rittner, 2012, Molecular pharmaceutics.